Literature DB >> 34008172

Spatiotemporal Phylodynamics of Hepatitis C Among People Who Inject Drugs in India.

Steven J Clipman1, Shruti H Mehta2, Mary A Rodgers3, Priya Duggal1,2, Aylur K Srikrishnan4, Shanmugam Saravanan4, Pachamuthu Balakrishnan4, Canjeevaran K Vasudevan4, Stuart C Ray1, Muniratnam S Kumar4, Thomas C Quinn1,5, Gavin A Cloherty3, Gregory M Lucas1, Sunil S Solomon1,4.   

Abstract

BACKGROUND AND AIMS: Implementing effective interventions for HCV requires a detailed understanding of local transmission dynamics and geospatial spread. Little is known about HCV phylodynamics, particularly among high-burden populations, such as people who inject drugs (PWID). APPROACH AND
RESULTS: We used 483 HCV sequences and detailed individual-level data from PWID across four Indian cities. Bayesian phylogeographic analyses were used to evaluate transmission hotspots and geospatial diffusion of the virus. Phylogenetic cluster analysis was performed to infer epidemiologic links and factors associated with clustering. A total of 492 HIV sequences were used to draw comparisons within the same population and, in the case of coinfections, evaluate molecular evidence for shared transmission pathways. Overall, 139/483 (28.8%) of HCV sequences clustered with a median cluster size of 3 individuals. Genetically linked participants with HCV were significantly younger and more likely to be infected with HCV subtype 3b as well as to live and inject close to one another. Phylogenetic evidence suggests likely ongoing HCV infection/reinfection with limited support for shared HIV/HCV transmission pathways. Phylogeographic analyses trace historic HCV spread back to Northeastern India and show diffusion patterns consistent with drug trafficking routes.
CONCLUSIONS: This study characterizes HCV phylodynamics among PWID in a low and middle-income country setting. Heterogeneity and recent genetic linkage of HCV across geographically disparate Indian states suggest that targeted interventions could help prevent reimportation of virus through drug trafficking routes.
© 2021 The Authors. Hepatology published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2021        PMID: 34008172      PMCID: PMC8756458          DOI: 10.1002/hep.31912

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.298


  31 in total

1.  Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study.

Authors:  Sunil Suhas Solomon; Shruti H Mehta; Aylur K Srikrishnan; Suniti Solomon; Allison M McFall; Oliver Laeyendecker; David D Celentano; Syed H Iqbal; Santhanam Anand; Canjeevaram K Vasudevan; Shanmugam Saravanan; Gregory M Lucas; Muniratnam S Kumar; Mark S Sulkowski; Thomas C Quinn
Journal:  Lancet Infect Dis       Date:  2014-12-03       Impact factor: 25.071

2.  Bayesian Evaluation of Temporal Signal in Measurably Evolving Populations.

Authors:  Sebastian Duchene; Philippe Lemey; Tanja Stadler; Simon Y W Ho; David A Duchene; Vijaykrishna Dhanasekaran; Guy Baele
Journal:  Mol Biol Evol       Date:  2020-11-01       Impact factor: 16.240

3.  ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCV.

Authors:  Peter Ferenci; David Bernstein; Jacob Lalezari; Daniel Cohen; Yan Luo; Curtis Cooper; Edward Tam; Rui T Marinho; Naoky Tsai; Anders Nyberg; Terry D Box; Ziad Younes; Pedram Enayati; Sinikka Green; Yaacov Baruch; Bal Raj Bhandari; Florin Alexandru Caruntu; Thomas Sepe; Vladimir Chulanov; Ewa Janczewska; Giuliano Rizzardini; Judit Gervain; Ramon Planas; Christophe Moreno; Tarek Hassanein; Wangang Xie; Martin King; Thomas Podsadecki; K Rajender Reddy
Journal:  N Engl J Med       Date:  2014-05-04       Impact factor: 91.245

Review 4.  Review article: treatment as prevention - targeting people who inject drugs as a pathway towards hepatitis C eradication.

Authors:  J D Leask; J F Dillon
Journal:  Aliment Pharmacol Ther       Date:  2016-05-20       Impact factor: 8.171

5.  Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection.

Authors:  William O Osburn; Brian E Fisher; Kimberly A Dowd; Giselle Urban; Lin Liu; Stuart C Ray; David L Thomas; Andrea L Cox
Journal:  Gastroenterology       Date:  2009-09-24       Impact factor: 22.682

Review 6.  Global estimates of prevalence of HCV infection among injecting drug users.

Authors:  Carmen Aceijas; Tim Rhodes
Journal:  Int J Drug Policy       Date:  2007-08-07

7.  Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection.

Authors:  Nezam Afdhal; Stefan Zeuzem; Paul Kwo; Mario Chojkier; Norman Gitlin; Massimo Puoti; Manuel Romero-Gomez; Jean-Pierre Zarski; Kosh Agarwal; Peter Buggisch; Graham R Foster; Norbert Bräu; Maria Buti; Ira M Jacobson; G Mani Subramanian; Xiao Ding; Hongmei Mo; Jenny C Yang; Phillip S Pang; William T Symonds; John G McHutchison; Andrew J Muir; Alessandra Mangia; Patrick Marcellin
Journal:  N Engl J Med       Date:  2014-04-11       Impact factor: 91.245

8.  Hepatitis C virus treatment as prevention in an extended network of people who inject drugs in the USA: a modelling study.

Authors:  Alexei Zelenev; Jianghong Li; Alyona Mazhnaya; Sanjay Basu; Frederick L Altice
Journal:  Lancet Infect Dis       Date:  2017-11-15       Impact factor: 25.071

Review 9.  Opium trade and the spread of HIV in the Golden Crescent.

Authors:  Syeda Ayesha Farooq; Mohammad Hafiz Rasooly; Syed Hani Abidi; Kayvon Modjarrad; Syed Ali
Journal:  Harm Reduct J       Date:  2017-07-21

10.  Phylodynamics with Migration: A Computational Framework to Quantify Population Structure from Genomic Data.

Authors:  Denise Kühnert; Tanja Stadler; Timothy G Vaughan; Alexei J Drummond
Journal:  Mol Biol Evol       Date:  2016-04-09       Impact factor: 16.240

View more
  2 in total

1.  Molecular Epidemiology and Baseline Resistance of Hepatitis C Virus to Direct Acting Antivirals in Croatia.

Authors:  Petra Simicic; Anamarija Slovic; Leona Radmanic; Adriana Vince; Snjezana Zidovec Lepej
Journal:  Pathogens       Date:  2022-07-19

2.  Plasma Virome Reveals Blooms and Transmission of Anellovirus in Intravenous Drug Users with HIV-1, HCV, and/or HBV Infections.

Authors:  Yanpeng Li; Le Cao; Mei Ye; Rong Xu; Xin Chen; Yingying Ma; Ren-Rong Tian; Feng-Liang Liu; Peng Zhang; Yi-Qun Kuang; Yong-Tang Zheng; Chiyu Zhang
Journal:  Microbiol Spectr       Date:  2022-06-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.